Skip to main content

Table 1 Patient overview

From: Immunotherapy Bridge 2019 and Melanoma Bridge 2019: meeting abstracts

Patient overview

N (%)

Women (%)

Men (%)

Cohort

520 (100)

249 (47.8)

271 (52.2)

Genus

Women

249 (47.8)

249 (100)

0 (0)

Men

271 (52.2)

0 (0)

100 (0)

Localisation

Colon dx

241 (46.3)

117 (46.9)

124 (45.7)

Transverse

47 (9)

23 (9.2)

24 (8.8)

Colon sin

41 (8)

25 (19.1)

16 (5.9)

Sigmoid

182 (35)

79 (31.7)

103 (38.1)

Undetermined

9 (1.7)

5 (2.1)

4 (1.5)

Stage

II

230 (44.2)

108 (43.4)

122 (45.1)

III

290 (55.8)

141 (56.6)

149 (54.9)

Treatment

Surgery

275 (52.9)

136 (54.6)

139 (51.2)

Surgery + adj chemotherapy

245 (47.1)

113 (45.4)

132 (48.7)